Based on the role of AR SUMO1ylation in regulating AR activity, inhibition of the ability of SENP1 to deSUMOylate AR would be a potential therapeutic strategy for inhibiting PCa progression. The gene discussed is AR; the disease is posterior cortical atrophy.